name: TRACH BASE PLATE,ADHESIVE LARYVOX #48140


name: TRACH BASE PLATE,ADHESIVE LARYVOX #48130


name: TRACH BASE PLATE,ADHESIVE LARYVOX #48120


name: TRACH BASE PLATE,ADHESIVE LARYVOX #48100


name: HEAT & MOISTURE EXCHANGER,LARYVOX #49810


name: HEAT & MOISTURE EXCHANGER,LARYVOX #49802


name: HEAT & MOISTURE EXCHANGER,LARYVOX #49800


name: DRESSING,ALLEVYN PLUS ADHESIVE SACRUM 6.75IN X 6.75IN U#66000856


name: CATHERIZATION SET,FOLEY 18FR BARD #300318A


name: BANDAGE KIT,LEG COMPRESSION,LYMPHEDEMA #BPKTFULLLEG


name: Carbon-13 Magnetic Resonance Spectroscopy


name: Organisation for Economic Co-Operation and Development


name: Health Services for Persons with Disabilities


name: Anodal Stimulation Transcranial Direct Current Stimulation


name: Cathodal Stimulation Transcranial Direct Current Stimulation


name: Cytochrome P-450 Monooxygenase Inhibitors


name: Aromatic Amino Acid Decarboxylase Inhibitors


name: Carbamoyl Phosphate Synthetase I Activators


name: Environmental Restoration and Remediation


name: Repetitive Transcranial Electrical Stimulation


name: Transcranial Alternating Current Stimulation


name: Practice Management Services, Veterinary


name: Nursing station casework (physical object)


name: Examination of cellophane tape preparation slide for pinworm


name: Radiation treatment delivery, superficial and/or ortho voltage, per day


name: Crown-porcelain fused to predominantly base metal (Single Restoration Only)


name: Crown-porcelain fused to predominantly base metal (Fixed Partial Denture Retainers)


name: Radiation treatment delivery, >=1 MeV; simple


name: Radiation treatment delivery, >=1 MeV; complex


name: Patient care - patient profile query reason


name: Glucose-6-phosphate dehydrogenase (G6PD) (Chemistry Procedures)


name: Triiodothyronine T3 (Chemistry Procedures)


name: Probe with target amplification technique


name: Helicobacter pylori (Chemistry Procedures)


name: Prostate specific antigen (PSA) measurement


name: Multisection^WO & W contrast IV:Find:Pt:Head>Orbit:Doc:MR


name: continuous electrocardiogram monitoring atrial fibrillation with rapid ventricular response


name: Bone length:Len:Pt:{First bone reference}+{Second bone reference}:Qn:Measured


name: EGR2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Ablation therapy for reduction or eradication of 1 or more bone tumors (eg, metastasis) including adjacent soft tissue when involved by tumor extension, percutaneous, including imaging guidance when performed; cryoablation


name: Gonadotropin, chorionic (hCG) (Chemistry Procedures)


name: CSTB gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: CMT axonal gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: AS+PWS gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: ALDOB gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Registered Palliative/Hospice Respiratory Therapist


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Tarina Fe 1/20 28 Day]


name: Unit Quantity - Maximum number of items covered


name: paid non-payee payable prior-period electronic count


name: Nursing Service Related Providers; Technician


name: Colonoscopy, flexible; with endoscopic stent placement (includes pre- and post-dilation and guide wire passage, when performed)


name: Supraventricular Tachyarrhythmia ECG Assessment


name: International Normalized Ratio of Prothrombin Time


name: Revision of total elbow arthroplasty, including allograft when performed; humeral or ulnar component


name: conjunto de referencias de lenguaje castellano para América Latina


name: Comparative nutrition assessment standards panel:-:Pt:^Patient:-


name: Ileoscopy, through stoma; with placement of endoscopic stent (includes pre- and post-dilation and guide wire passage, when performed)


name: Dartmouth COOP Functional Assessment Charts - 4 weeks:-:Pt:^Patient:-


name: Dartmouth COOP Functional Assessment Charts - 4 weeks


name: genome sequence analysis nuclear encoded mitochondrial genes panel


name: MAAA with mRNA gene expression profiling, 58 genes, FFPE tissue, for breast cancer recurrance risk


name: MAAA with mRNA expression profiling by real-time RT-PCR of 21 genes, FFPE tissue, for breast cancer recurrence risk


name: multianalyte assays with algorithmic analyses for oncology with PCR expression analysis of 51 genes


name: 22q11.2 deletion prior risk:Likelihood:Pt:^Fetus:Qn:Based on general population risk


name: Monosomy X prior risk:Likelihood:Pt:^Fetus:Nar:Based on maternal age


name: Monosomy X prior risk:Likelihood:Pt:^Fetus:Qn:Based on maternal age


name: Trisomy 13 prior risk:Likelihood:Pt:^Fetus:Qn:Based on maternal age


name: Trisomy 13 prior risk:Likelihood:Pt:^Fetus:Nar:Based on maternal age


name: Trisomy 18 prior risk:Likelihood:Pt:^Fetus:Nar:Based on maternal age


name: Trisomy 18 prior risk:Likelihood:Pt:^Fetus:Qn:Based on maternal age


name: Trisomy 21 prior risk:Likelihood:Pt:^Fetus:Nar:Based on maternal age


name: Trisomy 21 prior risk:Likelihood:Pt:^Fetus:Qn:Based on maternal age


name: Food and beverage intake panel:-:Pt:^Patient:-


name: Food and nutrient intake panel:-:Pt:^Patient:-


name: Food and nutrition history panel:-:Pt:^Patient:-


name: HCV RNA screening tests - Meaningful Use set


name: HCV RNA screening tests - Meaningful Use set:-:Pt:^Patient:-


name: Nutrition related anthropometric measurements panel


name: {1 (1.25 ML hyaluronidase, human recombinant 160 UNT/ML Injection) / 1 (25 ML immunoglobulin G, human 100 MG/ML Injection) } Pack [Hyqvia 2.5 G / 25 ML Kit]


name: HEDIS 2015-2018 Value Set - Cholesterol Tests Other Than LDL


name: HEDIS 2015-2018 Value Set - Cholesterol Tests Other Than LDL:-:Pt:^Patient:-


name: Anoscopy; diagnostic, with high-resolution magnification (HRA) (eg, colposcope, operating microscope) and chemical agent enhancement, including collection of specimen(s) by brushing or washing, when performed


name: {6 (0.8 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]) } Pack [Humira Pediatric Crohn's Disease Starter Package (6 count)]


name: expectorants - ammonium chloride (medication)


name: {3 (Kentucky bluegrass pollen extract 100 IR / orchard grass pollen extract 100 IR / perennial rye grass pollen extract 100 IR / sweet vernal grass pollen extract 100 IR / Timothy grass pollen extract 100 IR Sublingual Tablet [Oralair 100]) / 6 (Kentucky bluegrass pollen extract 300 IR / orchard grass pollen extract 300 IR / perennial rye grass pollen extract 300 IR / sweet vernal grass pollen extract 300 IR / Timothy grass pollen extract 300 IR Sublingual Tablet [Oralair 300]) } Pack [Oralair Children and Adolescents Sample Kit]


name: Nutrition related anthropometric measurements panel:-:Pt:^Patient:-


name: Nutrition status observation panel:-:Pt:^Patient:-


name: Oxygen therapy at arrival:Find:Pt:^Patient:Ord


name: Arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder, hip, knee, subacromial bursa); without ultrasound guidance


name: Arthrocentesis, aspiration and/or injection, intermediate joint or bursa (eg, temporomandibular, acromioclavicular, wrist, elbow or ankle, olecranon bursa); without ultrasound guidance


name: Arthrocentesis, aspiration and/or injection, intermediate joint or bursa (eg, temporomandibular, acromioclavicular, wrist, elbow or ankle, olecranon bursa); with ultrasound guidance, with permanent recording and reporting


name: Arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder, hip, knee, subacromial bursa); with ultrasound guidance, with permanent recording and reporting


name: Arthrocentesis, aspiration and/or injection, small joint or bursa (eg, fingers, toes); with ultrasound guidance, with permanent recording and reporting


name: Other anti-dementia drug combinations in ATC


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; insertion of central cannula(e) by sternotomy or thoracotomy, 6 years and older


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; insertion of central cannula(e) by sternotomy or thoracotomy, birth through 5 years of age


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; insertion of peripheral (arterial and/or venous) cannula(e), open, birth through 5 years of age


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; insertion of peripheral (arterial and/or venous) cannula(e), percutaneous, birth through 5 years of age (includes fluoroscopic guidance, when performed)


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; insertion of peripheral (arterial and/or venous) cannula(e), percutaneous, 6 years and older (includes fluoroscopic guidance, when performed)


name: Arthrocentesis, aspiration and/or injection, small joint or bursa (eg, fingers, toes); without ultrasound guidance


name: emergency medical services - HL7PublishingDomain


name: Temporomandibular joint disc (physical object)


name: {1 (100 ML immunoglobulin G, human 100 MG/ML Injection) / 1 (5 ML hyaluronidase, human recombinant 160 UNT/ML Injection) } Pack [Hyqvia 10 G / 100 ML Kit]


name: {1 (2.5 ML hyaluronidase, human recombinant 160 UNT/ML Injection) / 1 (50 ML immunoglobulin G, human 100 MG/ML Injection) } Pack [Hyqvia 5 G / 50 ML Kit]


name: {1 (10 ML hyaluronidase, human recombinant 160 UNT/ML Injection) / 1 (200 ML immunoglobulin G, human 100 MG/ML Injection) } Pack [Hyqvia 20 G / 200 ML Kit]


name: {1 (15 ML hyaluronidase, human recombinant 160 UNT/ML Injection) / 1 (300 ML immunoglobulin G, human 100 MG/ML Injection) } Pack [Hyqvia 30 G / 300 ML Kit]


name: Colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique


name: PROMIS short form - pain interference 8a - version 1.0:-:Pt:^Patient:-:PROMIS


name: PROMIS short form - pain interference 8a - version 1.0


name: Provider responsible for medication monitoring


name: Provider responsible for medication monitoring:Pn:Pt:Provider:Nom


name: Risk assessment and screening note:Find:Pt:{Setting}:Doc:{Role}


name: Sequence number in substance administration series:Num:Pt:^Patient:Qn


name: Sequence number in substance administration series


name: Comparative nutrition assessment standards panel


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; reposition peripheral (arterial and/or venous) cannula(e), percutaneous, 6 years and older (includes fluoroscopic guidance, when performed)


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; reposition peripheral (arterial and/or venous) cannula(e), open, birth through 5 years of age (includes fluoroscopic guidance, when performed)


name: Fall risk assessment note:Find:Pt:{Setting}:Doc:{Role}


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; reposition peripheral (arterial and/or venous) cannula(e), open, 6 years and older (includes fluoroscopic guidance, when performed)


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; reposition of central cannula(e) by sternotomy or thoracotomy, birth through 5 years of age (includes fluoroscopic guidance, when performed)


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; reposition peripheral (arterial and/or venous) cannula(e), percutaneous, birth through 5 years of age (includes fluoroscopic guidance, when performed)


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; reposition central cannula(e) by sternotomy or thoracotomy, 6 years and older (includes fluoroscopic guidance, when performed)


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; removal of central cannula(e) by sternotomy or thoracotomy, birth through 5 years of age


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; removal of central cannula(e) by sternotomy or thoracotomy, 6 years and older


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; removal of peripheral (arterial and/or venous) cannula(e), percutaneous, birth through 5 years of age


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; removal of peripheral (arterial and/or venous) cannula(e), open, birth through 5 years of age


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; removal of peripheral (arterial and/or venous) cannula(e), open, 6 years and older


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; removal of peripheral (arterial and/or venous) cannula(e), percutaneous, 6 years and older


name: Electrophysiologic evaluation of subcutaneous implantable defibrillator (includes defibrillation threshold evaluation, induction of arrhythmia, evaluation of sensing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic parameters)


name: Esophageal biopsy report with a statement about dysplasia (present, absent, or indefinite, and if present, contains appropriate grading) (PATH)


name: Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; insertion of peripheral (arterial and/or venous) cannula(e), open, 6 years and older


name: Documentation of medical reason(s) for not offering assistance with end of life issues (e.g., patient in hospice care, patient in terminal phase) during the measurement period


name: Documentation of medical reason(s) for not receiving annual screening for hcv infection (e.g., decompensated cirrhosis indicating advanced disease [i.e., ascites, esophageal variceal bleeding, hepatic encephalopathy], hepatocellular carcinoma, waitlist for organ transplant, limited life expectancy, other medical reasons)


name: Exome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis


name: Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), colon, with interpretation and report


name: Immunohistochemistry or immunocytochemistry, per specimen; each multiplex antibody stain procedure


name: In situ hybridization (eg, FISH), per specimen; each additional single probe stain procedure


name: In situ hybridization (eg, FISH), per specimen; each multiplex probe stain procedure


name: Exome sequence analysis, each comparator exome


name: Local excision of single lesion of cervix with fulguration


name: Magnetic cell separation system (physical object)


name: FaLessa Kit, 0.02 mg-1 mg-0.1 mg oral kit


name: Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: up to 5 mev


name: Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session


name: Genome sequence analysis each comparator genome


name: Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), using computer-assisted technology, per specimen; each multiplex probe stain procedure


name: Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), manual, per specimen; each multiplex probe stain procedure


name: Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), using computer-assisted technology, per specimen; each additional single probe stain procedure


name: Nuclear encoded mitochondrial genes (eg, neurologic or myopathic phenotypes), genomic sequence panel, must include analysis of at least 100 genes, including BCS1L, C10orf2, COQ2, COX10, DGUOK, MPV17, OPA1, PDSS2, POLG, POLG2, RRM2B, SCO1, SCO2, SLC25A4, SUCLA2, SUCLG1, TAZ, TK2, and TYMP


name: MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; promoter methylation analysis


name: Myelography via lumbar injection, including radiological supervision and interpretation; cervical


name: Multitherapy Systems, External Energy Stimulation


name: HEDIS 2015-2018 Value Set - Digoxin Level:-:Pt:^Patient:-


name: HEDIS 2015-2018 Value Set - Digoxin Level


name: HEDIS 2015-2018 Value Set - Glucose Tests


name: HEDIS 2015-2018 Value Set - Glucose Tests:-:Pt:^Patient:-


name: HEDIS 2015-2020 Value Set - HbA1c Tests:-:Pt:^Patient:-


name: HEDIS 2015-2020 Value Set - LDL-C Tests:-:Pt:^Patient:-


name: HEDIS 2015, 2016 Value Set - Pregnancy Test Exclusion:-:Pt:^Patient:-


name: HEDIS 2015, 2016 Value Set - Pregnancy Test Exclusion


name: HEDIS 2015-2018 Value Set - PSA Test Exclusion:-:Pt:^Patient:-


name: HEDIS 2015-2018 Value Set - PSA Test Exclusion


name: HEDIS 2015-2018 Value Set - PSA Tests:-:Pt:^Patient:-


name: KRAS gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Myelography via lumbar injection, including radiological supervision and interpretation; lumbosacral


name: Myelography via lumbar injection, including radiological supervision and interpretation; 2 or more regions (eg, lumbar/thoracic, cervical/thoracic, lumbar/cervical, lumbar/thoracic/cervical)


name: Negative pressure wound therapy, (eg, vacuum assisted drainage collection), utilizing disposable, non-durable medical equipment including provision of exudate management collection system, topical application(s), wound assessment, and instructions for ongoing care, per session; total wound(s) surface area greater than 50 square centimeters


name: Percutaneous vertebral augmentation, including cavity creation (fracture reduction and bone biopsy included when performed) using mechanical device (eg, kyphoplasty), 1 vertebral body, unilateral or bilateral cannulation, inclusive of all imaging guidance; thoracic


name: Percutaneous vertebral augmentation, including cavity creation (fracture reduction and bone biopsy included when performed) using mechanical device (eg, kyphoplasty), 1 vertebral body, unilateral or bilateral cannulation, inclusive of all imaging guidance; lumbar


name: Percutaneous vertebral augmentation, including cavity creation (fracture reduction and bone biopsy included when performed) using mechanical device (eg, kyphoplasty), 1 vertebral body, unilateral or bilateral cannulation, inclusive of all imaging guidance; each additional thoracic or lumbar vertebral body


name: Myelography via lumbar injection, including radiological supervision and interpretation; thoracic


name: Environmental condition panel:-:Pt:{Nursing unit}:-:NMMDS


name: Number of visits to this healthcare entity in the last 12Mo:NRat:12Mo:^Patient:Qn


name: Number of visits to this healthcare entity in the last 12MO


name: Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; multiple lead transvenous implantable defibrillator system


name: Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead transvenous implantable defibrillator system


name: Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; single lead transvenous implantable defibrillator system


name: Access restriction by regulation:Type:Pt:^Patient:Nom


name: Advance directive - request for antibiotics:Find:Pt:^Patient:Ord


name: Advance directive - request for antibiotics


name: Advance directive - request for intubation:Find:Pt:^Patient:Ord


name: Advance directive - request for intubation


name: Advance directive - request for IV fluid and support


name: Advance directive - request for IV fluid and support:Find:Pt:^Patient:Ord


name: Advance directive - request for life support:Find:Pt:^Patient:Ord


name: Advance directive - request for life support


name: Advance directive - request for resuscitation that differs from cardiopulmonary resuscitation:Find:Pt:^Patient:Ord


name: Advance directive - request for resuscitation that differs from cardiopulmonary resuscitation


name: Advance directive - request for tube feeding


name: {2 (dasabuvir 250 MG Oral Tablet) / 2 (ombitasvir 12.5 MG / paritaprevir 75 MG / ritonavir 50 MG Oral Tablet) } Pack [Viekira Pak]


name: Advance directive - request for tube feeding:Find:Pt:^Patient:Ord


name: Biobank specimens are stored and available for research


name: Biobank specimens are stored and available for research:PrThr:Pt:^Patient:Ord


name: Transcatheter mitral valve repair, percutaneous approach, including transseptal puncture when performed; additional prosthesis(es) during same session (List separately in addition to code for primary procedure)


name: Measurement of Skeletal muscle relaxants


name: Ileoscopy, through stoma; with transendoscopic balloon dilation


name: Ileoscopy, through stoma; diagnostic, including collection of specimen(s) by brushing or washing, when performed


name: Anti human globulin test technique, indirect


name: Solid organ or hematolymphoid neoplasm or disorder, 51 or greater genes, genomic sequence analysis panel, interrogation for sequence variants and copy number variants or rearrangements, or isoform expression or mRNA expression levels, if performed; DNA analysis or combined DNA and RNA analysis


name: Hematolymphoid neoplasm or disorder, genomic sequence analysis panel, 5-50 genes, interrogation for sequence variants, and copy number variants or rearrangements, or isoform expression or mRNA expression levels, if performed; DNA analysis or combined DNA and RNA analysis


name: Solid organ neoplasm, genomic sequence analysis panel, 5-50 genes, interrogation for sequence variants and copy number variants or rearrangements, if performed; DNA analysis or combined DNA and RNA analysis


name: Open treatment of rib fracture(s) with internal fixation, includes thoracoscopic visualization when performed, unilateral; 4-6 ribs


name: Open treatment of rib fracture(s) with internal fixation, includes thoracoscopic visualization when performed, unilateral; 7 or more ribs


name: Whole mitochondrial genome large deletion analysis panel (eg, Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia), including heteroplasmy detection, if performed


name: Whole mitochondrial genome (eg, Leigh syndrome, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes [MELAS], myoclonic epilepsy with ragged-red fibers [MERFF], neuropathy, ataxia, and retinitis pigmentosa [NARP], Leber hereditary optic neuropathy [LHON]), genomic sequence, must include sequence analysis of entire mitochondrial genome with heteroplasmy detection


name: X-linked intellectual disability (XLID) (eg, syndromic and non-syndromic XLID); genomic sequence analysis panel, must include sequencing of at least 60 genes, including ARX, ATRX, CDKL5, FGD1, FMR1, HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL, RPS6KA3, and SLC16A2


name: X-linked intellectual disability (XLID) (eg, syndromic and non-syndromic XLID); duplication/deletion gene analysis, must include analysis of at least 60 genes, including ARX, ATRX, CDKL5, FGD1, FMR1, HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL, RPS6KA3, and SLC16A2


name: Expression (foundation metadata concept)


name: Dietary cholesterol absorption inhibitor


name: ALUMINUM CHLOROHYDRATE 12.3 g in 100 mL TOPICAL LIQUID [Antiperspirant Deodorant Roll-on Jafra Daily]


name: calcium acetate / magnesium acetate / potassium acetate / potassium chloride / sodium acetate / sodium gluconate


name: calcium chloride / magnesium chloride / potassium acetate / sodium acetate / sodium chloride


name: CATHETER,INTERMITTENT 16FR LOFRIC HYDRO-KIT #9831640


name: CATHETER,INTERMITTENT 16FR LOFRIC PRIMO #4131640


name: CATHETER,INTERMITTENT COUDE 12FR PECO #PU812C


name: CATHETER,INTERMITTENT COUDE 14FR RUSCH #EC143


name: CATHETER,INTERMITTENT COUDE 16FR LOFRIC PRIMO #4151640


name: CATHETER,INTERMITTENT COUDE 18FR PECO #PU818C


name: DRESSING,ALLEVYN AG ADHESIVE 3IN X 3IN U#66020970


name: DRESSING,ALLEVYN AG ADHESIVE 5IN X 5IN U#66020973


name: DRESSING,ALLEVYN AG ADHESIVE 7IN X 7IN U#66020976


name: DRESSING,ALLEVYN AG GENTLE 2IN X 2IN,U#66800455


name: DRESSING,ALLEVYN AG GENTLE 4IN X 4IN,U#66800456


name: DRESSING,ALLEVYN AG GENTLE 6IN X 6IN,U#66800458


name: DRESSING,ALLEVYN AG GENTLE 8IN X 8IN,U#66800459


name: DRESSING,ALLEVYN GENTLE BORDER 4IN X 4IN #66800270


name: DRESSING,SORBAVIEW 3.75IN X 6.25IN #SV37UDT


name: TRACHEOSTOMY TUBE HOLDER,LARGE MARPAC #102


name: TRACHEOSTOMY TUBE HOLDER,MEDIUM MARPAC #101


name: TRACH TUBE,SZ 7 CUFFLESS AIR-LON #515120


name: SUCTION TUBE ATTACHMENT DEVICE BUSSE #303


name: ALUMINUM CHLOROHYDRATE 100 g in 100 mL TOPICAL LIQUID [hair minimizing antiperspirant deodorant roll-on Jafra Daily]


name: ALUMINUM CHLOROHYDRATE 12.3 g in 100 mL TOPICAL LIQUID [Skin brightening antiperspirant deodorant roll-on Jafra Daily]


name: {1 (59 ML) (benzoyl peroxide 30 MG/ML Topical Lotion) / 1 (118 ML) (salicylic acid 15 MG/ML Medicated Liquid Soap) } Pack


name: AVOBENZONE 3 g in 100 mL / OCTISALATE 4.7 g in 100 mL / OCTOCRYLENE 8.4 g in 100 mL TOPICAL LOTION [Nivea Men Sensitive Protective]


name: AVOBENZONE 30 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 70 mg in 1 g TOPICAL CREAM [Lancome Paris Bienfait MultiVital Broad Spectrum SPF 30 Sunscreen]


name: Vesicular Monoamine Transporter 2 Inhibitor [EPC]


name: EUCALYPTUS OIL 0.05 in 10 mL / ALLANTOIN 0.1 in 10 mL TOPICAL LIQUID [PHS Hair Science Adv Revitalizing Scalp Ampoule]


name: ALUMINUM CHLOROHYDRATE 12.3 g in 100 mL TOPICAL LIQUID [Sensitive Skin antiperspirant deodorant roll-on Jafra Daily]


name: ALUMINUM SESQUICHLOROHYDRATE 0.15 g in 100 mL TOPICAL SPRAY [UTRASURE]


name: {42 (rivaroxaban 15 MG Oral Tablet) / 9 (rivaroxaban 20 MG Oral Tablet) } Pack


name: {42 (rivaroxaban 15 MG Oral Tablet [Xarelto]) / 9 (rivaroxaban 20 MG Oral Tablet [Xarelto]) } Pack [Xarelto Kit]


name: {1 (15 ML hyaluronidase, human recombinant 160 UNT/ML Injection) / 1 (300 ML immunoglobulin G, human 100 MG/ML Injection) } Pack


name: {1 (1.25 ML hyaluronidase, human recombinant 160 UNT/ML Injection) / 1 (25 ML immunoglobulin G, human 100 MG/ML Injection) } Pack


name: {1 (2.5 ML hyaluronidase, human recombinant 160 UNT/ML Injection) / 1 (50 ML immunoglobulin G, human 100 MG/ML Injection) } Pack


name: {1 (100 ML immunoglobulin G, human 100 MG/ML Injection) / 1 (5 ML hyaluronidase, human recombinant 160 UNT/ML Injection) } Pack


name: {1 (10 ML hyaluronidase, human recombinant 160 UNT/ML Injection) / 1 (200 ML immunoglobulin G, human 100 MG/ML Injection) } Pack


name: {24 (ethinyl estradiol 0.025 MG / norethindrone 0.8 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Chewable Tablet) } Pack


name: {1 (acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Capsule) } Pack


name: {1 (acetaminophen 500 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 1 (acetaminophen 500 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack


name: {1 (acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 1 (acetaminophen 325 MG / diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack


name: OCTINOXATE 4.49 mg in 1 mL / OXYBENZONE 2 mg in 1 mL / ZINC OXIDE 20.9 mg in 1 mL TOPICAL LIQUID [CD DIORSKIN CITY DEFENSE Toxin Shield Pollution UV Advanced Protection with sunscreen Broad Spectrum SPF50]


name: {1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 1 (acetaminophen 325 MG / diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack


name: Retractors, Surgical, Spine, Lumbar, Laminectomy


name: sickle cell anemia information sensitivity policy


name: ASCORBIC ACID 0.005 in 5 mL TOPICAL LIQUID [Dr. Cellapy SR Premium Solution]


name: ALLANTOIN 0.5 in 25 g TOPICAL PATCH [Cellapy MGF Hydro Gel Intense Mask]


name: ALLANTOIN 0.2 g in 100 g TOPICAL PATCH [M-Rose Seaweed Hydrogel Mask]


name: TITANIUM DIOXIDE 5 g in 100 mL TOPICAL LOTION [Buttermilk Future Resist Foundation Broad Spectrum SPF 20 Delilah]


name: TITANIUM DIOXIDE 5 g in 100 mL TOPICAL LIQUID [Chestnut Future Resist Foundation Broad Spectrum Foundation Delilah]


name: TITANIUM DIOXIDE 5 g in 100 mL TOPICAL LIQUID [Maple Future Resist Foundation Broad Spectrum SPF 20 Foundation Delilah]


name: OCTINOXATE 0.066 g in 1 g / OXYBENZONE 0.015 g in 1 g TOPICAL LIPSTICK [ESIKA HYDRACOLOR 2 IN 1 Highly Moisturizing and coloring SPF 25 (ROSA ROMANTICA FEMME) - PINK]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 30 mg in 1 g / OCTISALATE 40 mg in 1 g / OCTOCRYLENE 20 mg in 1 g / OXYBENZONE 50 mg in 1 g TOPICAL SPRAY [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF30]


name: OXYBENZONE 40 mg in 1 mL / AVOBENZONE 15 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 30 mg in 1 mL TOPICAL LOTION [Neutrogena Oil Free Moisture Broad Spectrum SPF15]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL / OXYBENZONE 60 mg in 1 mL TOPICAL LOTION [Lancome Paris Bienfait UV 50 Plus Broad Spectrum SPF 50 Plus Water Resistant 80 Minutes Super Fluid Facial Sunscreen]


name: AVOBENZONE 20 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g TOPICAL LOTION [Lancome Paris Absolue Hand Premium Bx Broad Spectrum SPF 15 Sunscreen Absolute Anti Age Spot Unifying And Replenishing Treatment]


name: TITANIUM DIOXIDE 5 g in 100 mL TOPICAL LIQUID [Time Frame Future Resist Foundation Broad Spectrum SPF 20 Delilah Cosmetics]


name: DIMETHICONE 10 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL STICK [Mentholatum Natural Ice Cherry]


name: TITANIUM DIOXIDE 5.2 g in 100 g / ZINC OXIDE 1.1 g in 100 g TOPICAL LOTION [ECLIPSE SPF 50 ALL SHADES]


name: OCTINOXATE 75 mg in 1 g TOPICAL LIPSTICK [Beyond Color Plumping Lip Conditioner]


name: {28 (estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet) } Pack [Lopreeza 1/0.5 28 Day]


name: {28 (estradiol 0.5 MG / norethindrone acetate 0.1 MG Oral Tablet) } Pack [Lopreeza 0.5/0.1 28 Day]


name: Vitafol-OB Plus DHA Prenatal Supplement Plus DHA KIT


name: SUNSCREEN 30-50/PHYSICAL BLOCK/PABA-FREE, COMBO LOTION


name: SUNSCREEN 30-50/PHYSICAL BLOCK/PABA-FREE COMBO FACIAL CREAM


name: SUNSCREEN 30-50/AVOBENZONE/PABA-FREE COMBO LOTION


name: SUNSCREEN 30-50/AVOBENZONE/ PABA-FREE COMBO SPRAY


name: {3 (Kentucky bluegrass pollen extract 100 IR / orchard grass pollen extract 100 IR / perennial rye grass pollen extract 100 IR / sweet vernal grass pollen extract 100 IR / Timothy grass pollen extract 100 IR Sublingual Tablet) / 6 (Kentucky bluegrass pollen extract 300 IR / orchard grass pollen extract 300 IR / perennial rye grass pollen extract 300 IR / sweet vernal grass pollen extract 300 IR / Timothy grass pollen extract 300 IR Sublingual Tablet) } Pack


name: iodine / isopropyl alcohol / potassium iodide


name: Kentucky bluegrass pollen extract / orchard grass pollen extract / perennial rye grass pollen extract / sweet vernal grass pollen extract / Timothy grass pollen extract


name: DRESSING,POLYMEM AG 8IN X 8IN,FERRIS #1088


name: DRESSING,MEDIHONEY HCS ADHESIVE 4.5IN X 4.5IN


name: DRESSING,ALLEVYN GENTLE BORDER LITE 5.5CM X 12CM #66800836


name: CATHETER,RED RUBBER 22FR 16IN BARD #9422


name: CATHERIZATION SET,INTERMITTENT 12FR C#CS1120


name: CATHERIZATION SET,INTERMITTENT 12FR C#28422


name: psychiatry disorder information sensitivity


name: sexual assault, abuse, or domestic violence information sensitivity


name: sexuality and reproductive health information sensitivity


name: sexually transmitted disease information sensitivity


name: gender and sexual orientation information sensitivity


name: living arrangement information sensitivity


name: patient requested information sensitivity


name: sensitive service provider information sensitivity


name: comply with jurisdictional privacy policy


name: comply with organizational privacy policy


name: comply with organizational security policy


name: clinical decision support intervention review


name: no disclosure without subject authorization


name: no disclosure without information subject's consent directive


name: no disclosure without organizational authorization


name: no disclosure to patient, family or caregivers without attending provider's authorization


name: no redisclosure without consent directive


name: no redisclosure without information subject's consent directive


name: no disclosure without jurisdictional authorization


name: no disclosure without originator authorization


name: security alteration integrity observation


name: security integrity confidence observation


name: security integrity provenance observation


name: security integrity provenance asserted by observation


name: security integrity provenance reported by observation


name: administered outside recommended schedule or practice


name: starts after or concurrent with start of


name: starts after start of, ends after end of


name: starts before start of, ends before end of


name: Human Cells, Tissues, and Cellular and Tissue-Based Products Recovery


name: starts before or concurrent with start of


name: medium authentication level of assurance


name: low authentication process level of assurance


name: basic authentication process level of assurance


name: medium authentication process level of assurance


name: high authentication process level of assurance


name: low token and credential management level of assurance


name: basic token and credential management level of assurance


name: medium token and credential management level of assurance


name: low identity proofing level of assurance


name: basic identity proofing level of assurance


name: medium identity proofing level of assurance


name: high identity proofing level of assurance


name: basic non-repudiation level of assurance


name: medium non-repudiation level of assurance


name: authentication process level of assurance value


name: token and credential management level of assurance value)


name: high token and credential management level of assurance


name: non-repudiation level of assurance value


name: International Classification of Diseases, Ninth Revision, Clinical Modification, 2014


name: International Classification of Diseases, Ninth Revision, Clinical Modification, Metathesaurus additional entry terms, 2014


name: Infusion of 4-Factor Prothrombin Complex Concentrate


name: Implantation of epiretinal visual prosthesis


name: Revision or replacement of epiretinal visual prosthesis


name: Metathesaurus CMS Formulary Reference File


name: {1 (dextromethorphan hydrobromide 1 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution) / 1 (diphenhydramine hydrochloride 1.25 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution) } Pack


name: HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 26 mg in 1 mL TOPICAL CREAM [ISA KNOX 365 SUNSCREEN BROAD SPECTRUM SPF 50 Plus]


name: BIOTIN 0.168 g in 280 mL / PYRITHIONE ZINC 0.168 g in 280 mL / NIACINAMIDE 0.84 g in 280 mL / DEXPANTHENOL 1.4 g in 280 mL TOPICAL SHAMPOO [NDM SCALP]


name: CERAMIDE 3 0.05 in 200 mL TOPICAL LOTION [Cellapy A Repair]


name: CERAMIDE 3 0.1 in 100 mL TOPICAL CREAM [Cellapy A Repair Cream]


name: SALICYLIC ACID 0.45 g in 90 mL / NIACINAMIDE 0.27 g in 90 mL TOPICAL LIQUID [NDM SCALP Tonic]


name: Aluminum Zirconium Tetrachlorohydrex GLY 19.0 g in 100 g TOPICAL STICK [Axe Night Antiperspirant Deodorant]


name: HOMOSALATE 3500 mg in 35 g / OCTOCRYLENE 2800 mg in 35 g / OCTISALATE 1750 mg in 35 g / AVOBENZONE 1050 mg in 35 g TOPICAL LOTION [Avail Body with Sunscreen]


name: CATHETER,EXTERNAL SILICONE MED COLOPLAST #6200


name: DRESSING,ALLEVYN HEEL 4.5IN X 5.5IN,U#66007630


name: DRESSING,ALLEVYN PLUS ADHESIVE 5IN X 5IN U#66000805


name: DRESSING,ALLEVYN PLUS ADHESIVE 5IN X 9IN U#66000807


name: HEAT & MOISTURE EXCHANGER,CURAPLEX #301452


name: SUNSCREEN 30-50/AVOBENZONE/PABA-FREE COMBO STICK


name: ADHESIVE,DARO HYDROBOND LIQUID #B-200-ES


name: PRECISION XCEED PRO (GLUCOSE) TEST STRIP


name: acetaminophen / aspirin / diphenhydramine


name: Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen


name: TITANIUM DIOXIDE 9.0 g in 100 mL / ZINC OXIDE 6.3 g in 100 mL TOPICAL CREAM [YOUR SKIN BUT BETTER FAIR]


name: acetaminophen / chlophedianol / pyrilamine


name: ALUMINUM SESQUICHLOROHYDRATE 200 mg in 1 g TOPICAL STICK [Power Stick XJ Coolblast Xtreme]


name: Ethinyl Estradiol/Norgestimate;Ethinyl Estradiol/Norgestimate;Ethinyl Estradiol/Norgestimate 35 MCG-0.18 MG; 35 MCG-0.215 MG; 35 MCG-0.25 MG Oral Tablet


name: {3 (0.8 ML adalimumab 50 MG/ML Prefilled Syringe) } Pack


name: {3 (0.8 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]) } Pack [Humira Pediatric Crohn's Disease Starter Package (3 count)]


name: ALUMINUM SESQUICHLOROHYDRATE 200 mg in 1 g TOPICAL STICK [Soft Whisper Cucumber Green Tea]


name: Octinoxate 50 mg in 1 mL / Octisalate 28 mg in 1 mL TOPICAL LOTION [Nu Skin Nu Colour advanced tinted moisturizer broad spectrum SPF 15 - Beige]


name: Aortic dysfunction or dilation (eg, Marfan syndrome, Loeys Dietz syndrome, Ehler Danlos syndrome type IV, arterial tortuosity syndrome); genomic sequence analysis panel, must include sequencing of at least 9 genes, including FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10, SMAD3, and MYLK


name: Bilateral screening digital breast tomosynthesis


name: Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique


name: 1p36 deletion prior risk:Likelihood:Pt:^Fetus:Nar:Based on general population risk


name: Dartmouth COOP Functional Assessment Charts - 2 weeks:-:Pt:^Patient:-


name: Digital tomosynthesis of bilateral breasts


name: 22q11.2 deletion prior risk:Likelihood:Pt:^Fetus:Nar:Based on general population risk


name: Dartmouth COOP Functional Assessment Charts - 2 weeks


name: Date of supracervical hysterectomy:Date:Pt:^Patient:Qn


name: Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps


name: Colonoscopy through stoma; with endoscopic mucosal resection


name: Colonoscopy, flexible; with endoscopic mucosal resection


name: Date of intrauterine device insertion:Date:Pt:^Patient:Qn


name: Date of total hysterectomy:Date:Pt:^Patient:Qn


name: OCTINOXATE 3.57 g in 1 g / OCTISALATE 2.375 g in 1 g / OXYBENZONE 2 g in 1 g / AVOBENZONE 1.5 g in 1 g TOPICAL CREAM [FLAWLESS FUTURE MOISTURE]


name: TITANIUM DIOXIDE 5.0 mg in 100 mL / ZINC OXIDE 5.0 mg in 100 mL TOPICAL CREAM [LUMINIZING MOISTURE TINT SUNSCREEN BROAD SPECTRUM SPF 20 BLUSH]


name: Aluminum Zirconium Tetrachlorohydrex GLY 19.2 g in 100 g TOPICAL STICK [Degree MotionSense Adventure Antiperspirant Deodorant]


name: Aluminum Zirconium Tetrachlorohydrex GLY 18.2 g in 100 g TOPICAL STICK [Degree Cool Rush Antiperspirant and Deodorant]


name: OCTOCRYLENE 5 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / OXYBENZONE 3 g in 100 mL / TITANIUM DIOXIDE 3 g in 100 mL TOPICAL CREAM [Sun Protection Creme SPF 30 PLUS Exel Clarifying Line]


name: OCTINOXATE 7.5 g in 100 mL / ZINC OXIDE 3 g in 100 mL TOPICAL CREAM [defy time protector moisturizer broad spectrum SPF 15 Jafra time dynamics]


name: AVOBENZONE 2.5 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 4 g in 100 mL / OXYBENZONE 2 g in 100 mL TOPICAL CREAM [recover skin boosting moisturizer broad spectrum SPF 15 Jafra gold dynamics]


name: {24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 4 (ferrous fumarate 75 MG Oral Tablet) } Pack [Gildess 24 Fe 28 Day]


name: Vascular Endothelial Growth Factor Receptor 2-directed Antibody


name: Vascular Endothelial Growth Factor Receptor 2 Antagonist


name: Protease-activated Receptor-1 Antagonist [EPC]


name: 1p36 deletion prior risk:Likelihood:Pt:^Fetus:Qn:Based on general population risk


name: Colonoscopy through stoma; with endoscopic stent placement (including pre- and post-dilation and guide wire passage, when performed)


name: {2 (dasabuvir 250 MG Oral Tablet) / 2 (ombitasvir 12.5 MG / paritaprevir 75 MG / ritonavir 50 MG Oral Tablet) } Pack


name: chondroitin sulfates / glucosamine / ibuprofen


name: L1 protein, human papillomavirus type 11 vaccine / L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine / L1 protein, human papillomavirus type 31 vaccine / L1 protein, human papillomavirus type 33 vaccine / L1 protein, human papillomavirus type 45 vaccine / L1 protein, human papillomavirus type 52 vaccine / L1 protein, human papillomavirus type 58 vaccine / L1 protein, human papillomavirus type 6 vaccine


name: betamethasone / clotrimazole / gentamicin


name: iodine / isopropyl alcohol / sodium iodide


name: benzocaine / capsaicin / lidocaine / methyl salicylate


name: Aortic dysfunction or dilation (eg, Marfan syndrome, Loeys Dietz syndrome, Ehler Danlos syndrome type IV, arterial tortuosity syndrome); duplication/deletion analysis panel, must include analyses for TGFBR1, TGFBR2, MYH11, and COL3A1


name: Colonoscopy, flexible; with decompression (for pathologic distention) (eg, volvulus, megacolon), including placement of decompression tube, when performed


name: Colonoscopy through stoma; with decompression (for pathologic distention) (eg, volvulus, megacolon), including placement of decompression tube, when performed


name: IRRIGATION KIT W/PISTON SYRINGE AMSURE #AS127


name: DRESSING,PURACOL PLUS AG 4IN X 4IN MEDLINE#MSC8744


name: DRESSING,PURACOL PLUS AG 2IN X 2IN MEDLINE#MSC8722


name: DRESSING,PURACOL PLUS 4IN X 4IN MEDLINE#MSC8644


name: DRESSING,PURACOL PLUS 2IN X 2IN MEDLINE#MSC8622


name: DRESSING,HYDROFERA BLUE 2.5IN OSTOMY #HBRF2650


name: DRESSING,AQUACEL AG FOAM NON-ADHESIVE 8IN X 8IN #420646


name: CATHETER,INTERMITTENT COUDE 14FR RELIAMED #PIC1416C


name: CATHETER,INTERMITTENT APOGEE 12FR H#1048


name: CATHETER,INTERMITTENT APOGEE 12FR H#1047


name: BAG,LEG LARGE 32 OZ WITH EXTENSION TUBE RUSCH #453932


name: Behavior treatment by protocol administered by technician first 30 minutes


name: Magnetic Resonance Imaging of the Abdomen without Contrast


name: Magnetic Resonance Imaging of the Pelvis without Contrast


name: Rheumatoid arthritis disease activity score confidence interval


name: MSH2 gene+MLH1 gene+MSH6 gene mutation analysis limited to known familial mutations


name: dRVVT.hexagonal phase phospholipid actual/Normal


name: Are you able to reach and get down an object (such as a can of soup) from above your head


name: In general, how would you rate your child's physical health


name: In general, would you say your child's quality of life is


name: How often does your child feel really sad


name: How many D in the past W did your child miss taking one or more medications


name: Rate all your child's health care in the last 12Mo


name: In general, how would you rate your child's mental health, including mood and ability to think


name: In general, would you say your child's health is


name: How often does your child have fun with friends


name: How often does your child feel that you listen to his or her ideas


name: How often have you had four or more drinks in one D during the past Y


name: HCV antibody RIBA tests - Meaningful Use set


name: HCV antibody screening tests - Meaningful Use set


name: Coagulation surface induced.lupus sensitive/Coagulation surface induced.lupus sensitive.excess phospholipid


name: Lupus anticoagulant three screening tests W Reflex


name: Lupus anticoagulant three screening tests W Reflex panel


name: Aids or devices usually used for dressing & grooming, arising, eating, &or walking


name: Hepatitis A virus RNA & Parvovirus B19 DNA panel


name: Do you sometimes drink alcoholic beverages


name: PCORnet common data model set - version 1.0


name: Over the past W, are you able to go up two or more flights of stairs


name: Over the past W, are you able to move heavy objects


name: Over the past W, are you able to lift heavy objects


name: Over the past W, are you able to wait in line for 15 minutes


name: Over the past W, are you able to do outside work (such as yard work)


name: Evaluator global assessment of disease activity - 0-10 (0.5 increments) numeric rating


name: Patient global assessment of disease activity - 0-10 numeric rating


name: Over the past W, are you able to do chores such as vacuuming or yard work


name: Over the past W, are you able to get in and out of a car


name: Over the past W, are you able to run errands and shop


name: Over the past W, are you able to turn faucets on and off


name: Over the past W, are you able to open jars which have been previously opened


name: Over the past W, are you able to open car doors


name: Over the past W, are you able to bend down and pick up clothing from the floor


name: Over the past W, are you able to reach and get down a 5 pound object (such as a bag of sugar) from just above your head


name: Over the past W, are you able to get on and off the toilet


name: Over the past W, are you able to take a tub bath


name: Over the past W, are you able to wash and dry your body


name: Over the past W, are you able to climb up five steps


name: Over the past W, are you able to walk outdoors on flat ground


name: Over the past W, are you able to open a new milk carton


name: Over the past W, are you able to lift a full cup or glass to your mouth


name: Over the past W, are you able to cut your meat


name: Over the past W, are you able to get in and out of bed


name: Over the past W, are you able to stand up from a straight chair


name: Over the past W, are you able to shampoo your hair


name: Over the past W, are you able to dress yourself, including shoelaces and buttons


name: Coagulation surface induced.hexagonal phase phospholipid actual/Normal


name: During the past 4Ws, what was the hardest physical activity you could do for at least 2 minutes


name: During the past 4Ws, how much have you been bothered by emotional problems such as feeling anxious, depressed, irritable or downhearted and blue


name: During the past 4Ws, how much difficulty have you had doing your usual activities or tasks, both inside and outside the house because of your physical and emotional health


name: During the past 4Ws, has your physical and emotional health limited your social activities with family, friends, neighbors or groups


name: During the past 4Ws, how much bodily pain have you generally had


name: How would you rate your overall health now compared to 4Ws ago


name: During the past 4Ws, how would you rate your health in general


name: During the past 4Ws, was someone available to help you if you needed and wanted help


name: How have things been going for you during the past 4Ws


name: Other directives that have not otherwise been documented


name: Goals, preferences, and priorities for medical treatment


name: Guidance for percutaneous aspiration of fluid


name: Electronic health record implementation stage


name: Electronic health record implementation stage panel


name: BMPR1A gene mutation analysis limited to known familial mutations


name: AXIN2 gene deletion+duplication & full mutation analysis


name: AXIN2 gene mutation analysis limited to known familial mutations


name: How have things been going for you during the past 2Ws


name: During the past 2Ws, was someone available to help you if you needed and wanted help


name: During the past 2Ws, how would you rate your health in general


name: How would you rate your overall health now compared to 2Ws ago


name: During the past 2Ws, how much bodily pain have you generally had


name: During the past 2Ws, has your physical and emotional health limited your social activities with family, friends, neighbors or groups


name: During the past 2Ws, how much difficulty have you had doing your usual activities or tasks, both inside and outside the house because of your physical and emotional health


name: During the past 2Ws, how much have you been bothered by emotional problems such as feeling anxious, depressed, irritable or downhearted and blue


name: During the past 2Ws, what was the hardest physical activity you could do for at least 2 minutes


name: Lactate dehydrogenase.body fld/Lactate dehydrogenase.serum


name: Rheumatoid arthritis disease activity panel


name: Human immunodeficiency virus 1 & 2 tests - Meaningful Use set


name: TNM pathologic staging after surgery panel


name: TNM clinical staging before treatment panel


name: Comment on fetal Prader-Willi syndrome risk


name: Noninvasive prenatal fetal aneuploidy and microdeletion panel


name: Applicable certification agency for unit


name: Accreditation, certification, & licensure panel


name: Lupus anticoagulant two screening tests W Reflex panel


name: Lupus anticoagulant two screening tests W Reflex


name: DRVVT with 1:1 Pooled Normal Plasma actual/Normal


name: Coagulation surface induced.lupus sensitive with 1:1 Pooled Normal Plasma


name: Coagulation surface induced.lupus sensitive with 1:1 Pooled Normal Plasma actual/Normal


name: Coagulation surface induced.lupus sensitive.excess phospholipid actual/Normal


name: PCORI patient-reported outcomes core adult measures


name: PCORI patient-reported outcomes core pediatric measures


name: PCORI patient-reported outcomes recommended measures


name: PCORI patient-reported outcomes common measures - core and recommended


name: Have Trouble Doing Regular Leisure Activities with Others Question


name: How often do your parents listen to your ideas


name: Rate all your health care in the last 12Mo


name: AIP gene mutation analysis limited to known familial mutations


name: ATP7B gene mutation analysis limited to known familial mutations


name: TTR gene mutation analysis limited to known familial mutations


name: Within the last Mo, how often have you experienced physical factors


name: To what extent do you agree or disagree with cultural factors contributing to the phenomenon of complexity


name: To what extent do you agree or disagree with physical factors contributing to the phenomenon of complexity


name: Within the last Mo, how often have you experienced psychosocial factors


name: To what extent do you agree or disagree with psychosocial factors contributing to the phenomenon of complexity


name: Within the last Mo, how often have you experienced cultural factors


name: CDKN1B gene mutation analysis limited to known familial mutations


name: MEN1 gene mutation analysis limited to known familial mutations


name: Respiratory status without oxygen therapy during 2D assessment period


name: Respiratory status with oxygen therapy during 2D assessment period


name: Creatine kinase.aberrant band/Creatine kinase.total


name: Patient Centered Outcomes Research Network (PCORnet) Common Data Model (CDM) set


name: Patient Centered Outcomes Research Network (PCORnet) Common Data Model (CDM)


name: HL7 Consolidated Clinical Document Architecture (CCDA) set


name: Dartmouth Cooperative Functional Status Test (COOP) set


name: Patient-Centered Outcomes Research Institute (PCORI) set


name: HL7 Consolidated Clinical Document Architecture (CCDA)


name: Other fetal conditions/disorders (specify)


name: Other obstetrical or pregnancy complications (specify)


name: Other complications of placenta, cord, or membranes (specify)


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Mental health


name: Alcohol use disorder identification test-consumption:-:Pt:^Patient:-:AUDIT-C


name: Respiratory syncytial virus RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Respiratory syncytial virus RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar


name: Parainfluenza virus 4 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Parainfluenza virus 3 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Parainfluenza virus 2 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Parainfluenza virus 1 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Observation:Prid:Pt:BAL:Nom:Methenamine silver nitrate stain


name: Staphylococcus aureus.methicillin resistant isolate:PrThr:Pt:Pharynx:Ord:Organism specific culture


name: Influenza virus B RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Influenza virus B RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar


name: MBL2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Abbreviated Injury Scale panel:-:Pt:^Patient:-:AAAM


name: Abbreviated Injury Scale version code:Type:Pt:^Patient:Nom:AAAM


name: 6p25 & 6q23 & 11q & 8q24 & 9p21 chromosome partial aneuploidy:Find:Pt:Bld/Tiss:Doc:FISH


name: Rheumatoid arthritis disease activity score confidence interval:ScoreRange:Pt:Ser/Plas:SemiQn:VectraDA


name: MSH2 gene+MLH1 gene+MSH6 gene mutation analysis limited to known familial mutations:Find:Pt:Bld/Tiss:Doc:Molgen


name: Other significant causes or conditions of death:Find:Pt:^Fetus:Nom:US standard report of fetal death


name: Initiating cause or condition of death:Find:Pt:^Fetus:Nom:US standard report of fetal death


name: Moxifloxacin 2.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Moxifloxacin 1.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Moxifloxacin 0.5 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: levoFLOXacin 4.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: levoFLOXacin 2.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: levoFLOXacin 1.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: GALT gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: GLA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: ARSA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: GAA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: HEXA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: SGSH gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: NPC1 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: IDS gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: HEXB gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: IDUA gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Fetal chromosome 21 trisomy:PrThr:Pt:Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal chromosome 18 trisomy:PrThr:Pt:Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal chromosome 13 trisomy:PrThr:Pt:Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal chromosome 13+18+21+X+Y aneuploidy:PrThr:Pt:Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal chromosome 13 trisomy:Imp:Pt:Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal chromosome 18 trisomy:Imp:Pt:Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal chromosome X & Y aneuploidy:PrThr:Pt:Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal chromosome 21 trisomy:Imp:Pt:Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal chromosome 13+18+21 trisomy:PrThr:Pt:Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: dRVVT.hexagonal phase phospholipid actual/Normal:RelTime:Pt:PPP:Qn:Coag


name: Observation unit stay discharge:TmStp:Pt:^Patient:Qn:NAMCS


name: Canadian triage and acuity scale:Find:Pt:^Patient:Ord:CTAS


name: Are you able to reach and get down an object (such as a can of soup) from above your head:Find:Pt:^Patient:Ord:PROMIS


name: In general, how would you rate your child's physical health:Find:Pt:^Patient:Ord:PROMIS.PARENTPROXY


name: In general, would you say your child's quality of life is:Find:Pt:^Patient:Ord:PROMIS.PARENTPROXY


name: My child had trouble sleeping when he or she had pain in past 7D:Find:7D:^Patient:Ord:PROMIS.PARENTPROXY


name: My child felt stressed in past 7D:Find:7D:^Patient:Ord:PROMIS.PARENTPROXY


name: How often does your child feel really sad:Find:Pt:^Patient:Ord:PROMIS.PARENTPROXY


name: My child has a good life:Find:Pt:^Patient:Ord:NIH Toolbox


name: How many D in the past W did your child miss taking one or more medications:Num:1W:^Patient:Qn:SAMHSA


name: Rate all your child's health care in the last 12Mo:Score:12Mo:^Patient:Qn:AHRQ


name: In general, how would you rate your child's mental health, including mood and ability to think:Find:Pt:^Patient:Ord:PROMIS.PARENTPROXY


name: My child got tired easily in past 7D:Find:7D:^Patient:Ord:PROMIS.PARENTPROXY


name: In general, would you say your child's health is:Find:Pt:^Patient:Ord:PROMIS.PARENTPROXY


name: How often does your child have fun with friends:Find:Pt:^Patient:Ord:PROMIS.PARENTPROXY


name: How often does your child feel that you listen to his or her ideas:Find:Pt:^Patient:Ord:PROMIS.PARENTPROXY


name: My child felt uneasy in past 7D:Find:7D:^Patient:Ord:PROMIS.PARENTPROXY


name: Patient global assessment of disease activity - 0-10 (0.5 increments) numeric rating:Score:Pt:^Patient:Ord:Reported


name: Pain severity in the past W - 0-10 numeric rating:Score:1W:^Patient:Ord:Reported


name: t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript break points:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Abbreviated Injury Scale severity score:Score:Pt:^Patient:Ord:AAAM


name: Abbreviated Injury Scale predot code:ID:Pt:^Patient:Nom:AAAM


name: How often have you had four or more drinks in one D during the past Y:NRat:1Y:^Patient:Qn:Reported


name: HCV antibody RIBA tests - Meaningful Use set:-:Pt:^Patient:-:IB


name: HCV antibody screening tests - Meaningful Use set:-:Pt:^Patient:-


name: Coagulation surface induced.lupus sensitive/Coagulation surface induced.lupus sensitive.excess phospholipid:Ratio:Pt:PPP:Qn:Coag


name: Lupus anticoagulant three screening tests W Reflex:Imp:Pt:PPP:Nom:Coag


name: Lupus anticoagulant three screening tests W Reflex panel:-:Pt:PPP:-:Coag


name: Aids or devices usually used for hygiene, reach, grip, &or activities:Type:Pt:^Patient:Nom:HAQ


name: Help from another person usually needed for hygiene, reach, gripping and opening things, &or errands and chores:Find:Pt:^Patient:Nom:HAQ


name: Patient activity scale II:-:Pt:^Patient:-:PASII


name: Help from another person is usually needed for dressing & grooming, arising, eating, &or walking:Find:Pt:^Patient:Nom:HAQ


name: Aids or devices usually used for dressing & grooming, arising, eating, &or walking:Type:Pt:^Patient:Nom:HAQ


name: Deprecated PROMIS short form 8a - pain interference Tscore


name: Hepatitis A virus RNA & Parvovirus B19 DNA panel:-:Pt:Plas^Donor:-:Probe.amp.tar


name: Number of falls in the past 12Mo:NRat:12Mo:^Patient:Qn:Reported


name: Do you sometimes drink alcoholic beverages:Find:Pt:^Patient:Ord:Reported


name: PCORnet common data model set - version 1.0:-:Pt:^Patient:-:PCORnet


name: Over the past W, are you able to go up two or more flights of stairs:Find:1W:^Patient:Ord:HAQII


name: Over the past W, are you able to move heavy objects:Find:1W:^Patient:Ord:HAQII


name: Over the past W, are you able to lift heavy objects:Find:1W:^Patient:Ord:HAQII


name: Over the past W, are you able to wait in line for 15 minutes:Find:1W:^Patient:Ord:HAQII


name: Over the past W, are you able to do outside work (such as yard work):Find:1W:^Patient:Ord:HAQII


name: Evaluator global assessment of disease activity - 0-10 (0.5 increments) numeric rating:Score:Pt:^Patient:Ord:Observed


name: Patient global assessment of disease activity - 0-10 numeric rating:Score:Pt:^Patient:Ord:Reported


name: Simplified disease activity index:-:Pt:^Patient:-:SDAI


name: Clinical disease activity index:-:Pt:^Patient:-:CDAI


name: Over the past W, are you able to do chores such as vacuuming or yard work:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to get in and out of a car:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to run errands and shop:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to turn faucets on and off:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to open jars which have been previously opened:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to open car doors:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to bend down and pick up clothing from the floor:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to reach and get down a 5 pound object (such as a bag of sugar) from just above your head:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to get on and off the toilet:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to take a tub bath:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to wash and dry your body:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to climb up five steps:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to walk outdoors on flat ground:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to open a new milk carton:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to lift a full cup or glass to your mouth:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to cut your meat:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to get in and out of bed:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to stand up from a straight chair:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to shampoo your hair:Find:1W:^Patient:Ord:HAQ


name: Over the past W, are you able to dress yourself, including shoelaces and buttons:Find:1W:^Patient:Ord:HAQ


name: Guidance for drainage of abscess+placement of chest tube:Find:Pt:Chest>Pleural space.right:Doc:CT


name: Guidance for drainage of abscess+placement of chest tube:Find:Pt:Chest>Pleural space.right:Doc:RF


name: Coagulation surface induced.hexagonal phase phospholipid actual/Normal:RelTime:Pt:PPP:Qn:Coag


name: Views^W contrast EP:Find:Pt:Chest>Spine.thoracic epidural space:Doc:RF


name: During the past 4Ws, what was the hardest physical activity you could do for at least 2 minutes:Score:4W:^Patient:Ord:COOP


name: During the past 4Ws, how much have you been bothered by emotional problems such as feeling anxious, depressed, irritable or downhearted and blue:Score:4W:^Patient:Ord:COOP


name: During the past 4Ws, how much difficulty have you had doing your usual activities or tasks, both inside and outside the house because of your physical and emotional health:Score:4W:^Patient:Ord:COOP


name: During the past 4Ws, has your physical and emotional health limited your social activities with family, friends, neighbors or groups:Score:4W:^Patient:Ord:COOP


name: During the past 4Ws, how much bodily pain have you generally had:Score:4W:^Patient:Ord:COOP


name: How would you rate your overall health now compared to 4Ws ago:Score:Pt:^Patient:Ord:COOP


name: During the past 4Ws, how would you rate your health in general:Score:4W:^Patient:Ord:COOP


name: During the past 4Ws, was someone available to help you if you needed and wanted help:Score:4W:^Patient:Ord:COOP


name: How have things been going for you during the past 4Ws:Score:4W:^Patient:Ord:COOP


name: Emotional well being - FACT-GP:-:Pt:^Patient:-:FACIT


name: Functional well being - FACT-GP:-:Pt:^Patient:-:FACIT


name: Emotional well being - FANLTC:-:Pt:^Patient:-:FACIT


name: Social - family well being - FACT-GP:-:Pt:^Patient:-:FACIT


name: Physical well being - FACT-GP:-:Pt:^Patient:-:FACIT


name: Special treatments &or programs - none of above:-:Pt:^Patient:Set:MDSv3


name: Other directives that have not otherwise been documented:Find:Pt:^Patient:Nar:Reported


name: Powers granted to healthcare agent:Find:Pt:^Patient:Nar:Reported


name: Second alternate healthcare agent:Pn:Pt:^Patient:Nom:Reported


name: First alternate healthcare agent:Pn:Pt:^Patient:Nom:Reported


name: Thoughts on organ and tissue donations:Find:Pt:^Patient:Nar:Reported


name: Preferred location to spend final days if possible to choose:Loc:Pt:^Patient:Nar:Reported


name: Thoughts on cardiopulmonary resuscitation:Find:Pt:^Patient:Nar:Reported


name: Information to tell doctors if I have a severe, irreversible brain injury or illness and can't dress, feed, or bathe myself, or communicate my medical wishes, but can be kept alive:Find:Pt:^Patient:Nar:Reported


name: Information to tell doctors if my health deteriorates due to a terminal illness and I am unable to interact meaningfully with family, friends, or surroundings:Find:Pt:^Patient:Nar:Reported


name: Preference on consulting a supportive and palliative care team to help treat physical, emotional, and spiritual discomfort and support family:Find:Pt:^Patient:Nar:Reported


name: Decision to inform doctors and nurses about the role religion, faith, culture, or spirituality play in my life:Find:Pt:^Patient:Nar:Reported


name: Allowance to change advance directive preferences in the future regardless of mental state:Find:Pt:^Patient:Nar:Reported


name: Goals, preferences, and priorities for medical treatment:Find:Pt:^Patient:Nar:Reported


name: Chlamydia sp Ab:PrThr:Pt:Ser:Ord:Comp fix


name: Staphylococcus aureus.methicillin susceptible DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Bacterial vancomycin resistance vanD gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Guidance for drainage of abscess+placement of chest tube:Find:Pt:Chest>Pleural space.left:Doc:CT


name: Guidance for drainage of abscess+placement of chest tube:Find:Pt:Chest>Pleural space.left:Doc:RF


name: Guidance for percutaneous biopsy:Find:Pt:XXX>Intervertebral disc:Doc:RF


name: Guidance for percutaneous aspiration of fluid:Find:Pt:XXX>Intervertebral disc:Doc:RF


name: Guidance for percutaneous aspiration of fluid:Find:Pt:Neck>Spine.cervical intervertebral disc:Doc:CT


name: Guidance for drainage of abscess+placement of chest tube:Find:Pt:Chest>Pleural space.bilateral:Doc:RF


name: Guidance for drainage of abscess+placement of chest tube:Find:Pt:Chest>Pleural space.bilateral:Doc:CT


name: Electronic health record implementation stage:Find:Pt:{Nursing unit}:Ord:NMMDS


name: Electronic health record implementation stage panel:-:Pt:{Nursing unit}:-:NMMDS


name: BMPR1A gene mutation analysis limited to known familial mutations:Find:Pt:Bld/Tiss:Doc:Molgen


name: AXIN2 gene deletion+duplication & full mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: AXIN2 gene mutation analysis limited to known familial mutations:Find:Pt:Bld/Tiss:Doc:Molgen


name: Coccidioides immitis+posadasii Ab.IgM:PrThr:Pt:CSF:Ord:Immune diffusion


name: Bruton tyrosine kinase:Imp:Pt:B cells+monocytes:Nar:Flow cytometry


name: How have things been going for you during the past 2Ws:Score:2W:^Patient:Ord:COOP.WONCA


name: During the past 2Ws, was someone available to help you if you needed and wanted help:Score:2W:^Patient:Ord:COOP.WONCA


name: During the past 2Ws, how would you rate your health in general:Score:2W:^Patient:Ord:COOP.WONCA


name: How would you rate your overall health now compared to 2Ws ago:Score:Pt:^Patient:Ord:COOP.WONCA


name: During the past 2Ws, how much bodily pain have you generally had:Score:2W:^Patient:Ord:COOP.WONCA


name: During the past 2Ws, has your physical and emotional health limited your social activities with family, friends, neighbors or groups:Score:2W:^Patient:Ord:COOP.WONCA


name: During the past 2Ws, how much difficulty have you had doing your usual activities or tasks, both inside and outside the house because of your physical and emotional health:Score:2W:^Patient:Ord:COOP.WONCA


name: During the past 2Ws, how much have you been bothered by emotional problems such as feeling anxious, depressed, irritable or downhearted and blue:Score:2W:^Patient:Ord:COOP.WONCA


name: During the past 2Ws, what was the hardest physical activity you could do for at least 2 minutes:Score:2W:^Patient:Ord:COOP.WONCA


name: Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA:PrThr:Pt:Anorectal:Ord:Probe.amp.sig


name: Human papilloma virus 18 DNA:PrThr:Pt:Anorectal:Ord:Probe.amp.sig


name: Human papilloma virus 18+45 E6+E7 mRNA:PrThr:Pt:Cvx:Ord:Probe.amp.tar


name: Fetal sex:Find:Pt:Plas.cfDNA:Nom:Dosage of chromosome specific cf DNA


name: Peripheral sensory neuropathy grade:Imp:Pt:^Patient:Ord:NCICTC


name: Guidance for placement of nephrostomy tube:Find:Pt:Abdomen>Kidney:Doc:US


name: Multisection^WO & W contrast IV:Find:Pt:Head+Neck>Circle of Willis:Doc:CT.angio


name: Views^W contrast EP:Find:Pt:Abdomen>Spine.lumbar epidural space:Doc:RF


name: Guidance for percutaneous biopsy:Find:Pt:XXX>Bone marrow:Doc:RF


name: Fetal sex:Likelihood:Pt:Plas.cfDNA:Qn:Dosage of chromosome specific cf DNA


name: HIV 1+2 Ab & HIV1 p24 Ag:Prid:Pt:Ser/Plas/Bld:Nom:IA.rapid


name: Ova & parasites:Prid:Pt:Urine:Nom:Trichrome stain


name: Human papilloma virus 16 DNA:PrThr:Pt:Anorectal:Ord:Probe.amp.sig


name: Mononuclear cells:Num:Pt:Plr fld:Qn:Manual count


name: Mononuclear cells:Num:Pt:Pericard fld:Qn:Manual count


name: Lactate dehydrogenase.body fld/Lactate dehydrogenase.serum:RelRto:Pt:Body fld+Ser/Plas:Qn


name: Glucose^45M post 50 g lactose PO:SCnc:Pt:Ser/Plas:Qn


name: Rheumatoid arthritis disease activity panel:-:Pt:Ser/Plas:-:VectraDA


name: Rheumatoid arthritis disease activity score level:Imp:Pt:Ser/Plas:Ord:VectraDA


name: Rheumatoid arthritis disease activity score:Score:Pt:Ser/Plas:SemiQn:Calculated.VectraDA


name: Tumor necrosis factor receptor superfamily member 1A:MCnc:Pt:Ser/Plas:Qn


name: Vascular endothelial growth factor A:MCnc:Pt:Ser/Plas:Qn


name: Vascular adhesion protein 1:MCnc:Pt:Ser/Plas:Qn


name: HIV 1 & 2 tests - Meaningful Use set:-:Pt:^Patient:-


name: TNM pathologic staging after surgery panel:-:Pt:Cancer.XXX:-


name: TNM clinical staging before treatment panel:-:Pt:Cancer.XXX:-


name: National health care surveys report:Find:Pt:{Setting}:Doc:{Role}


name: Generic five level triage system:Find:Pt:^Patient:Ord:NAMCS


name: Four level triage system:Find:Pt:^Patient:Ord:NAMCS


name: Three level triage system:Find:Pt:^Patient:Ord:NAMCS


name: Patient seen in this ED in last 72H and discharged:Find:Pt:^Patient:Ord


name: Cell-free DNA.fetal/Cell-free DNA.total:Find:Pt:Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Cell-free DNA.fetal/Cell-free DNA.total:SFr:Pt:Plas.cfDNA:Qn:Dosage of chromosome specific cf DNA


name: Fetal sex:Find:Pt:WBC.DNA+Plas.cfDNA:Nom:Dosage of chromosome specific cf DNA


name: Comment on fetal 1p36 deletion risk:Txt:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal 1p36 deletion risk:Imp:Pt:WBC.DNA+Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal 1p36 deletion risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal 1p36 deletion risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Qn:Dosage of chromosome specific cf DNA


name: Comment on fetal 5p deletion risk:Txt:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal 5p deletion risk:Imp:Pt:WBC.DNA+Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal 5p deletion risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal 5p deletion risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Qn:Dosage of chromosome specific cf DNA


name: 5p deletion prior risk:Likelihood:Pt:^Fetus:Nar:Based on general population risk


name: 5p deletion prior risk:Likelihood:Pt:^Fetus:Qn:Based on general population risk


name: Comment on fetal Angelman syndrome risk:Txt:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal Angelman syndrome risk:Imp:Pt:WBC.DNA+Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal Angelman syndrome risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal Angelman syndrome risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Qn:Dosage of chromosome specific cf DNA


name: Angelman syndrome prior risk:Likelihood:Pt:^Fetus:Nar:Based on general population risk


name: Angelman syndrome prior risk:Likelihood:Pt:^Fetus:Qn:Based on general population risk


name: Comment on fetal Prader-Willi syndrome risk:Txt:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal Prader-Willi syndrome risk:Imp:Pt:WBC.DNA+Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal Prader-Willi syndrome risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal Prader-Willi syndrome risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Qn:Dosage of chromosome specific cf DNA


name: Prader-Willi syndrome prior risk:Likelihood:Pt:^Fetus:Nar:Based on general population risk


name: Prader-Willi syndrome prior risk:Likelihood:Pt:^Fetus:Qn:Based on general population risk


name: Comment on fetal 22q11.2 deletion risk:Txt:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal 22q11.2 deletion risk:Imp:Pt:WBC.DNA+Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal 22q11.2 deletion risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal 22q11.2 deletion risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Qn:Dosage of chromosome specific cf DNA


name: Comment on fetal Triploidy risk:Imp:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal triploidy risk:Imp:Pt:WBC.DNA+Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Comment on fetal Monosomy X risk:Txt:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal monosomy X risk:Imp:Pt:WBC.DNA+Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal monosomy X risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal monosomy X risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Qn:Dosage of chromosome specific cf DNA


name: Comment on fetal Trisomy 21 risk:Txt:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal trisomy 21 risk:Imp:Pt:WBC.DNA+Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal trisomy 21 risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal trisomy 21 risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Qn:Dosage of chromosome specific cf DNA


name: Comment on fetal Trisomy 18 risk:Txt:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal trisomy 18 risk:Imp:Pt:WBC.DNA+Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal trisomy 18 risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal trisomy 18 risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Qn:Dosage of chromosome specific cf DNA


name: Comment on fetal Trisomy 13 risk:Txt:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Fetal trisomy 13 risk:Imp:Pt:WBC.DNA+Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA


name: Fetal trisomy 13 risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA


name: Performing laboratory phone number:Tele:Pt:Facility:Nom


name: Fetal trisomy 13 risk:Likelihood:Pt:WBC.DNA+Plas.cfDNA:Qn:Dosage of chromosome specific cf DNA


name: Noninvasive prenatal fetal aneuploidy and microdeletion panel:-:Pt:WBC.DNA+Plas.cfDNA:-:Dosage of chromosome specific cf DNA


name: Noninvasive prenatal testing comment:Txt:Pt:^Fetus:Nar


name: Hepatitis A virus RNA+Parvovirus B19 DNA:Imp:Pt:Plas^Donor:Ord:Probe.amp.tar


name: Applicable licensing agency for unit:Type:Pt:{Nursing unit}:Nom:NMMDS


name: Applicable certification agency for unit:Type:Pt:{Nursing unit}:Nom:NMMDS


name: Accreditation, certification, & licensure panel:-:Pt:{Nursing unit}:-:NMMDS


name: Applicable accrediting agency for unit:Type:Pt:{Nursing unit}:Nom:NMMDS


name: Able to request or review patient chart:Type:Pt:Abstractor:Ord:MSCDM


name: Information source for data:Type:Pt:^Patient:Nom:PCORnet


name: Lupus anticoagulant two screening tests W Reflex panel:-:Pt:PPP:-:Coag


name: Lupus anticoagulant two screening tests W Reflex:Imp:Pt:PPP:Nom:Coag


name: DRVVT with 1:1 Pooled Normal Plasma:Time:Pt:PPP:Qn:Coag


name: DRVVT with 1:1 Pooled Normal Plasma actual/Normal:RelTime:Pt:PPP:Qn:Coag


name: Coagulation surface induced.lupus sensitive with 1:1 Pooled Normal Plasma:Time:Pt:PPP:Qn:Coag


name: Coagulation surface induced.lupus sensitive with 1:1 Pooled Normal Plasma actual/Normal:RelTime:Pt:PPP:Qn:Coag


name: Coagulation surface induced.lupus sensitive.excess phospholipid actual/Normal:RelTime:Pt:PPP:Qn:Coag


name: Coagulation surface induced.lupus sensitive percent correction:PctDiff:Pt:PPP:Qn:Coag


name: Coagulation surface induced.lupus sensitive.excess phospholipid:Time:Pt:PPP:Qn:Coag


name: Diseases with serologic evidence of immunity:Find:Pt:^Patient:Nom


name: Medication management note:Find:Pt:{Setting}:Doc:Primary care


name: Risk assessment and screening note:Find:Pt:{Setting}:Doc:Preventive medicine


name: Risk assessment and screening note:Find:Pt:{Setting}:Doc:Nurse


name: Medication management note:Find:Pt:{Setting}:Doc:Mental health


name: Note:Find:Pt:Long term care facility:Doc:{Role}


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Cardiovascular disease


name: Group counseling note:Find:Pt:{Setting}:Doc:Addiction psychiatry


name: PCORI patient-reported outcomes core adult measures:-:Pt:^Patient:-:PROMIS


name: PCORI patient-reported outcomes core pediatric measures:-:Pt:^Patient:-:PROMIS


name: PCORI patient-reported outcomes recommended measures:-:Pt:^Patient:-:PROMIS


name: PCORI patient-reported outcomes common measures - core and recommended:-:Pt:^Patient:-:PROMIS


name: I have trouble doing all of my regular leisure activities with others:Find:Pt:^Patient:Ord:PROMIS


name: How often do you feel really sad:Find:Pt:^Patient:Ord:PROMIS.PEDS


name: How often do you have fun with friends:Find:Pt:^Patient:Ord:PROMIS.PEDS


name: How often do your parents listen to your ideas:Find:Pt:^Patient:Ord:PROMIS.PEDS


name: I have a good life:Find:Pt:^Patient:Ord:NIH Toolbox


name: Rate all your health care in the last 12Mo:Score:12Mo:^Patient:Ord:AHRQ


name: Ebola Zaire virus RNA:PrThr:Pt:Plas/Bld:Ord:Probe.amp.tar


name: Hepatitis B virus surface Ag:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid


name: Hepatitis B virus surface Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid


name: Hepatitis B virus little e Ag:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid


name: GCDH gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: GCDH gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: KCNJ11 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: HNF4A gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: HNF1B gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: HNF1A gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: AIP gene mutation analysis limited to known familial mutations:Find:Pt:Bld/Tiss:Doc:Molgen


name: AIP gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Chromosome uniparental disomy:Prid:Pt:Amnio fld/CVS:Nar:Molgen


name: HTT gene.CAG repeats:PrThr:Pt:Amnio fld/CVS:Ord:Molgen


name: FXN gene.GAA repeats:PrThr:Pt:Amnio fld/CVS:Ord:Molgen


name: FGFR3 gene targeted mutation analysis:Find:Pt:Amnio fld/CVS:Doc:Molgen


name: APP gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: CDKN1B gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: DMD gene deletion+duplication:Find:Pt:Amnio fld/CVS:Doc:MLPA


name: ATP7B gene mutation analysis limited to known familial mutations:Find:Pt:Bld/Tiss:Doc:Molgen


name: TTR gene mutation analysis limited to known familial mutations:Find:Pt:Bld/Tiss:Doc:Molgen


name: SERPING1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hepatitis B virus core Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid


name: Dengue virus NS1 Ag:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid


name: First & Second trimester integrated maternal screen:Imp:Pt:^Patient:Nar


name: Other cells/Leukocytes:NFr:Pt:Plr fld:Qn:Manual count


name: Other cells/Leukocytes:NFr:Pt:Synv fld:Qn:Manual count


name: Other cells:NCnc:Pt:Plr fld:Qn:Manual count


name: Other cells/Leukocytes:NFr:Pt:Body fld:Qn:Manual count


name: Other cells/Leukocytes:NFr:Pt:Pericard fld:Qn:Manual count


name: Other cells:NCnc:Pt:Synv fld:Qn:Manual count


name: Other cells/Leukocytes:NFr:Pt:Periton fld:Qn:Manual count


name: Other cells:NCnc:Pt:Periton fld:Qn:Manual count


name: Within the last Mo, how often have you experienced physical factors:Find:1Mo:{Nursing unit}:Ord:NMMDS


name: To what extent do you agree or disagree with cultural factors contributing to the phenomenon of complexity:Find:Pt:{Nursing unit}:Ord:NMMDS


name: Total number of staff completing the environmental conditions survey:Num:Pt:{Nursing unit}:Qn:NMMDS


name: Nutrition status signs and symptoms:Find:Pt:^Patient:Nar


name: Adequacy of breastmilk &or formula:Find:Pt:^Patient:Ord


name: Number of pressure injuries:Num:Pt:^Patient:Qn


name: Age at event onset:Time:Pt:^Family member:Qn


name: Other cells/Cells:NFr:Pt:Lymph node:Qn:Manual count


name: Evaluation and management of anticoagulation note:Find:Pt:{Setting}:Doc:Pharmacology


name: Noninvasive prenatal testing overall interpretation:Imp:Pt:^Fetus:Ord


name: Hepatitis A virus RNA:Imp:Pt:Plas^Donor:Ord:Probe.amp.tar


name: Manual differential comment:Imp:Pt:Body fld:Nar


name: Hepatitis B virus little e Ab:PrThr:Pt:Ser/Plas/Bld:Ord:IA.rapid


name: Glucose^1.5H post dose triple bolus:SCnc:Pt:Ser/Plas:Qn


name: PDHA1 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: To what extent do you agree or disagree with physical factors contributing to the phenomenon of complexity:Find:Pt:{Nursing unit}:Ord:NMMDS


name: Within the last Mo, how often have you experienced psychosocial factors:Find:1Mo:{Nursing unit}:Ord:NMMDS


name: To what extent do you agree or disagree with psychosocial factors contributing to the phenomenon of complexity:Find:Pt:{Nursing unit}:Ord:NMMDS


name: Within the last Mo, how often have you experienced cultural factors:Find:1Mo:{Nursing unit}:Ord:NMMDS


name: Note:Find:Pt:Long term care facility:Doc:Nurse


name: Fall risk assessment note:Find:Pt:{Setting}:Doc:Nurse


name: CDKN1B gene mutation analysis limited to known familial mutations:Find:Pt:Bld/Tiss:Doc:Molgen


name: INS gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: MEN1 gene mutation analysis limited to known familial mutations:Find:Pt:Bld/Tiss:Doc:Molgen


name: Alcohol use disorder identification test:-:Pt:^Patient:-:AUDIT


name: Amniotic fluid or Chorionic villus sample


name: Alcohol Use Disorder Identification Test Alcohol Consumption Questions Questionnaire


name: Association for the Advancement of Automotive


name: Comparative nutrition assessment standards


name: post dose cyanocobalamin+intrinsic factor/Cobalamins


name: 2nd specimen/Streptococcus pneumoniae 14 Ab


name: 2nd specimen/Streptococcus pneumoniae 12f Ab


name: Supplies for Respiratory and Oxygen Equipment


name: Prosthetic Procedures - Breast Prostheses


name: Prosthetic Procedures - Nasal, Orbital, Auricular Prosthesis


name: Prosthetic Procedures - Prosthetic Socks


name: Excepted service provided at an off-campus, outpatient, provider-based department of a hospital


name: Separate encounter, a service that is distinct because it occurred during a separate encounter


name: Separate practitioner, a service that is distinct because it was performed by a different practitioner


name: Separate structure, a service that is distinct because it was performed on a separate organ/structure


name: Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service


name: Lithium ion battery, rechargeable, for non-prosthetic use, replacement


name: Replacement battery for external infusion pump owned by patient, lithium, 1.5 volt, each


name: Vacuum drainage collection unit and tubing kit, including all supplies needed for collection unit change, for use with implanted catheter, each


name: Implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components


name: Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants


name: Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants


name: Manual wheelchair accessory, push-rim activated power assist system


name: Blinded procedure for lumbar stenosis, percutaneous image-guided lumbar decompression (pild) or placebo-control, performed in an approved coverage with evidence development (ced) clinical trial


name: Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)


name: Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method


name: Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit


name: Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit


name: Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv


name: Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit


name: Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit


name: Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)


name: Hepatitis c antibody screening, for individual at high risk and other covered indication(s)


name: Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes


name: Documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons)


name: Primary non-small cell lung cancer lung biopsy and cytology specimen report documents classification into specific histologic type following iaslc guidance or classified as nsclc-nos with an explanation


name: Documentation of medical reason(s) for not including the histological type or nsclc-nos classification with an explanation (e.g. specimen insufficient or non-diagnostic, specimen does not contain cancer, or other documented medical reasons)


name: Documentation of medical or patient reason(s) for not ordering or performing screening for hcc. medical reason: comorbid medical conditions with expected survival < 5 years, hepatic decompensation and not a candidate for liver transplantation, or other medical reasons; patient reasons: patient declined or other patient reasons (e.g., cost of tests, time related to accessing testing equipment)


name: Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf


name: Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf


name: Upper extremity fracture orthosis, humeral, prefabricated, includes shoulder cap design, with or without joints, forearm section, may include soft interface, straps, includes fitting and adjustments


name: Transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device, excludes terminal device(s)


name: Antenna (external) for use with implantable diaphragmatic/phrenic nerve stimulation device, replacement, each


name: Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all of the devices


name: Sensor; invasive (e.g., subcutaneous), disposable, for use with artificial pancreas device system


name: Transmitter; external, for use with artificial pancreas device system


name: Receiver (monitor); external, for use with artificial pancreas device system


name: Services by a journal-listed christian science nurse, per hour


name: lansoprazole, clarithromycin and tinidazole


name: lansoprazole, amoxicillin and levofloxacin


name: azithromycin, fluconazole and secnidazole


name: atorvastatin, acetylsalicylic acid and ramipril


name: Antihypertensives for pulmonary arterial hypertension


name: OCTINOXATE 30 mg in 1 mL TOPICAL LIQUID [Giorgio Armani Maestro Summer Broad Spectrum SPF 15 Sunscreen]


name: HOMOSALATE 8 g in 100 mL / OCTISALATE 4 g in 100 mL / AVOBENZONE 3 g in 100 mL / OCTOCRYLENE 2 g in 100 mL TOPICAL CREAM [City Sunscreen serum Broad Spectrum SPF 30 Supergoop]


name: HOMOSALATE 10 g in 100 mL / OCTISALATE 2.6 g in 100 mL / OCTOCRYLENE 2.4 g in 100 mL / OXYBENZONE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL TOPICAL CREAM [Sun Protection Emulsion Face Broad Spectrum SPF 30 La Prairie Group]


name: AVOBENZONE 3.0 g in 100 mL / HOMOSALATE 7.0 g in 100 mL / OCTISALATE 5.0 g in 100 mL / OXYBENZONE 5.0 g in 100 mL TOPICAL LOTION [Sun Protection Body Sunscreen Broad Spectrum SPF 30 La Prairie]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 7 g in 100 g / OCTISALATE 5 g in 100 g / OXYBENZONE 2 g in 100 g TOPICAL STICK [Ultra Protection Stick Broad Spectrum SPF 40 La Prairie Switzerland]


name: {1 (acetaminophen 32.5 MG/ML / diphenhydramine hydrochloride 1.25 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution) } Pack


name: AVOBENZONE 75 mg in 1 mL / OCTINOXATE 50 mg in 1 mL / OCTISALATE 30 mg in 1 mL TOPICAL CREAM [Cellular Radiance Emulsion SPF 30 La Prairie]


name: AVOBENZONE 2 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 3 g in 100 mL TOPICAL CREAM [Anti-Aging Eye Broad Spectrum SPF 15 la prairie Switzerland]


name: ALLANTOIN 0.005 mg in 1 g TOPICAL CREAM [Scar Gel Advanced Formula]


name: AVOBENZONE 3 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL TOPICAL CREAM [Advanced Marine Biology Day SPF 20 La Prairie Group AG]


name: {1 (aspirin 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet) / 1 (aspirin 500 MG / dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet) } Pack


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 4 g in 100 mL / OCTINOXATE 6 g in 100 mL / OCTISALATE 3 g in 100 mL TOPICAL LIQUID [Defense Refresh Settingh Mist Broad Spectrum Sunscreen SPF 50 Supergoop]


name: OCTINOXATE 6 mg in 100 mL / OCTISALATE 3 mg in 100 mL / OCTOCRYLENE 2.4 mg in 100 mL / AVOBENZONE 3 mg in 100 mL TOPICAL CREAM [Youth Cell Day Broad Spectrum SPF-15 Sunscreen]


name: TITANIUM DIOXIDE 62 mg in 1 mL TOPICAL LIQUID [bareMinerals Complexion Rescue Broad Spectrum SPF 30 Buttercream 03]


name: BENAZEPRIL HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: OXYBENZONE 3 g in 100 g / OCTINOXATE 7.5 g in 100 g TOPICAL LIPSTICK [MediChoice Lip Balm SPF 15]


name: OCTINOXATE 75 mg in 1 g TOPICAL LIPSTICK [ultra color absolute]


name: OCTINOXATE 70 mg in 1 g / OCTISALATE 45 mg in 1 g / OXYBENZONE 40 mg in 1 g / AVOBENZONE 28 mg in 1 g TOPICAL CREAM [Anew Vitale Day]


name: HOMOSALATE 80 mg in 1 mL / OCTINOXATE 50 mg in 1 mL / OXYBENZONE 40 mg in 1 mL / AVOBENZONE 28.5 mg in 1 mL TOPICAL LOTION [Anew Vitale Day]


name: HOMOSALATE 80 mg in 1 g / OCTINOXATE 50 mg in 1 g / OXYBENZONE 40 mg in 1 g / AVOBENZONE 29 mg in 1 g TOPICAL CREAM [Anew Ultimate Day Multi-Performance]


name: camphor / capsaicin / Eucalyptus oil / menthol / methyl salicylate


name: TRACHEOSTOMY TUBE HOLDER,BRIDLE,SMALL DALE #249


name: VAD DRIVELINE MAINTENANCE KIT MED#DYNDC1488


name: CATHETER,SUCTION,WHISTLE TIP 14-16FR KIT BARD #0140100


name: DRESSING,REPLICARE ULTRA 6IN X 6IN U#59484700


name: DRESSING,REPLICARE THIN 6IN X 8IN U#59484200


name: DRESSING,REPLICARE THIN 3.5IN X 5.5IN U#59484100


name: DRESSING,REPLICARE THIN 2IN X 2.75IN U#59484000


name: DRESSING,REPLICARE 1.5IN X 2.5IN U#483000


name: DRESSING,MEDLINE ISLAND 6IN X 6IN #MSC3266


name: DRESSING,ALLEVYN THIN 4IN X 4IN,U#66047578


name: DRESSING,ALLEVYN THIN 2IN X 2.375IN,U#66047576


name: BANDAGE,ELASTIC (TETRA-FLEX LF) 4IN X 11YD


name: Clinical pathology service (qualifier value)


name: Standard base excess calculation technique


name: Patient-controlled analgesia infusion pump


name: dasabuvir / ombitasvir / paritaprevir / ritonavir


name: niacinamide 0.025 in 30 mL / PANTHENOL 0.01 in 30 mL / adenosine 0.0004 in 30 mL TOPICAL LIQUID [P1P Magic Whitening Antiaging]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL TOPICAL LOTION [Everyday Sunscreen SPF 50 Supergoop]


name: ALLANTOIN 0.12 mg in 600 mL / GLYCERIN 6 mg in 600 mL TOPICAL GEL [Seniorclean Bio]


name: Avobenzone 2.8 g in 100 mL / Octinoxate 7.5 g in 100 mL / Octisalate 5 g in 100 mL / OXYBENZONE 4 g in 100 mL TOPICAL CREAM [Anti-Aging Emulsion SPF 30]


name: OCTINOXATE 1.725 g in 1 mL / TITANIUM DIOXIDE 1.346 g in 1 mL TOPICAL CREAM [FLAWLESS FINISH PERFECTLY SATINB 24HR MAKEUP SHADE ALABASTER]


name: TITANIUM DIOXIDE 3.1680 g in 45.0000 g TOPICAL CREAM [Flawless by Sonya Aloe BB Creme Sandy]


name: Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor


name: Programmed Death Receptor-1 Blocking Antibody


name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle


name: SUCTION TUBE ATTACHMENT DEVICE KENDALL #505115


name: BAG,URINARY DRAINAGE 2000ML COVIDIEN #6308LL


name: TRACH TUBE,SZ 10 W/CUFF FENESTRATED SHLY #10-FEN


name: TRACH TIES FOAM EXTRA-LARGE POSEY #8197XL


name: POISE PAD,ULTIMATE ABSORB EXTRA COVERAGE


name: DRESSING,LYOFOAM MAX T 3.5IN X 3.5IN SC#603207


name: DRESSING,ALLEVYN HEEL 4.5IN X 5.5IN,U#66020414


name: DRESSING,ALLEVYN GENTLE BORDER SACRUM U#66020413


name: DRESSING,ALLEVYN GENTLE BORDER SACRUM U#66020404


name: DRESSING,ALLEVYN GENTLE BORDER MULTISITE U#66020405


name: DRESSING,ALLEVYN GENTLE BORDER LITE 6IN X 6IN #66020409


name: DRESSING,ALLEVYN GENTLE BORDER LITE 4IN X 4IN #66020408


name: DRESSING,ALLEVYN GENTLE BORDER HEEL U#66020407


name: DRESSING,ALLEVYN GENTLE BORDER 5IN X 5IN #66020403


name: DRESSING,ALLEVYN GENTLE BORDER 3IN X 3IN U#66020402


name: DRESSING,ALLEVYN ADHESIVE 5IN X 5IN U#66020401


name: DRESSING,ALLEVYN ADHESIVE 3IN X 3IN U#66020400


name: CATHETER,FOLEY SILICONE 2-WAY 22FR 5ML RUSCH #170605220


name: CATHETER,FOLEY COUDE PTFE 20FR 5ML RUSCH#318120


name: CATHETER,FOLEY COUDE PTFE 18FR 5ML RUSCH#318118


name: CATHETER,FOLEY COUDE PTFE 16FR 5ML RUSCH#318116


name: CATHETER,FOLEY COUDE 18FR 30ML BARD#0100L-18


name: CATHERIZATION SET,INTERMITTENT 16FR BARD #775516


name: activity-dependent neurotrophic factor, human


name: activity-dependent neurotrophic factor, rat


name: activity-dependent neurotrophic factor, mouse


name: G protein-coupled receptor 84, zebrafish


name: Body mass index follow up plan (record artifact)


name: Crown, porcelain fused to high noble metal


name: Total Amyloid Precursor Protein Measurement


name: Kurtzke Expanded Disability Status Scale Clinical Classification


name: crown - 3/4 cast high noble metal (Single Restoration Only)


name: retainer crown - 3/4 cast high noble metal (Fixed Partial Denture Retainers)


name: retainer crown - 3/4 cast predominantly base metal (Fixed Partial Denture Retainers)


name: Disability Rating Scale Clinical Classification


name: {6 (0.2 ML interferon beta-1a 0.044 MG/ML Auto-Injector) / 6 (0.5 ML interferon beta-1a 0.044 MG/ML Auto-Injector) } Pack


name: {6 (0.2 ML interferon beta-1a 0.044 MG/ML Auto-Injector [Rebif]) / 6 (0.5 ML interferon beta-1a 0.044 MG/ML Auto-Injector [Rebif]) } Pack [Rebif Rebidose]


name: {6 (0.8 ML adalimumab 50 MG/ML Auto-Injector) } Pack